1.
Horm Mol Biol Clin Investig
; 41(2)2019 Aug 09.
Article
in English
| MEDLINE
| ID: mdl-31398145
ABSTRACT
Uterine leiomyosarcoma (LMS) is rare but primary ovarian LMS is even rarer constituting less than 0.1% of all gynecologic disorders. Neither histologic features nor immunohistochemistry could be utilized to distinguish between uterine or ovarian origin. We illustrate a clinical case of metastatic LMS to the ovary in a woman with underlying uterine fibroid presenting with anemia with heavy menses.
Subject(s)
Leiomyosarcoma/diagnosis , Neoplasms, Second Primary/diagnosis , Ovarian Neoplasms/diagnosis , Uterine Neoplasms/diagnosis , Adult , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Biomarkers , Biopsy , Female , Humans , Immunohistochemistry , Leiomyosarcoma/etiology , Leiomyosarcoma/therapy , Neoplasms, Second Primary/etiology , Ovarian Neoplasms/etiology , Ovarian Neoplasms/therapy , Positron-Emission Tomography , Tomography, X-Ray Computed , Treatment Outcome , Uterine Neoplasms/etiology , Uterine Neoplasms/therapy
2.
J Obstet Gynaecol
; 37(5): 677-678, 2017 Jul.
Article
in English
| MEDLINE
| ID: mdl-28350528
